Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
33.85
-0.83 (-2.39%)
Mar 6, 2026, 4:00 PM EST - Market closed
Veracyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Veracyte stock have an average target of 45.13, with a low estimate of 37 and a high estimate of 50. The average target predicts an increase of 33.32% from the current stock price of 33.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Veracyte stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell Maintains $48 → $37 | Sell | Maintains | $48 → $37 | +9.31% | Mar 6, 2026 |
| Needham | Needham | Strong Buy Maintains $44 → $48 | Strong Buy | Maintains | $44 → $48 | +41.80% | Feb 26, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +47.71% | Jan 5, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $40 → $48 | Sell | Maintains | $40 → $48 | +41.80% | Dec 2, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $40 | Sell | Maintains | $28 → $40 | +18.17% | Nov 11, 2025 |
Financial Forecast
Revenue This Year
586.06M
from 517.15M
Increased by 13.33%
Revenue Next Year
659.48M
from 586.06M
Increased by 12.53%
EPS This Year
1.16
from 0.82
Increased by 41.07%
EPS Next Year
1.34
from 1.16
Increased by 15.63%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 609.5M | 697.9M | |||
| Avg | 586.1M | 659.5M | |||
| Low | 548.8M | 614.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.9% | 19.1% | |||
| Avg | 13.3% | 12.5% | |||
| Low | 6.1% | 4.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.72 | 1.86 | |||
| Avg | 1.16 | 1.34 | |||
| Low | 0.80 | 0.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 110.0% | 60.7% | |||
| Avg | 41.1% | 15.6% | |||
| Low | -2.0% | -22.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.